Compare Ascendis Pharma A/S (ASND) vs Lithium Americas Corp (LAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Lithium Americas Corp — how do they compare? Ascendis Pharma A/S trades at $254.8 (market cap $16.67B), while Lithium Americas Corp trades at $3.29 (market cap $1.18B). The key difference: Ascendis Pharma A/S is far larger — about 14.1× Lithium Americas Corp's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Lithium Americas Corp nearer its low. Which is the better fit depends on your goals.
| ASND | LAC | |
|---|---|---|
Market Cap | $16.67B | $1.18B |
Sector | Health | Basic Materials |
52-Week High | $277.18 | $10.05 |
52-Week Low | $189.74 | $2.71 |
Enterprise Value | $17.04B | $1.29B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Lithium Americas Corp
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →
